Chemoinformaics analysis of Erythro-9,10-Dibromopentacosane
| Molecular Weight | 510.483 | nRot | 22 |
| Heavy Atom Molecular Weight | 460.083 | nRig | 0 |
| Exact Molecular Weight | 508.228 | nRing | 0 |
| Solubility: LogS | -7.887 | nHRing | 0 |
| Solubility: LogP | 11.623 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 81.1897 |
| nHD | 0 | BPOL | 52.9203 |
| QED | 0.1 |
| Synth | 2.727 |
| Natural Product Likeliness | 0.252 |
| NR-PPAR-gamma | 0.035 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -5.087 |
| MDCK | 0.00000393 |
| BBB | 0.009 |
| PPB | 1.01829 |
| VDSS | 4.264 |
| FU | 0.0125756 |
| CYP1A2-inh | 0.105 |
| CYP1A2-sub | 0.165 |
| CYP2c19-inh | 0.371 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.498 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.027 |
| CYP3a4-inh | 0.237 |
| CYP3a4-sub | 0.107 |
| CL | 3.613 |
| T12 | 0.009 |
| hERG | 0.342 |
| Ames | 0.044 |
| ROA | 0.099 |
| SkinSen | 0.969 |
| Carcinogencity | 0.04 |
| EI | 0.938 |
| Respiratory | 0.481 |
| NR-Aromatase | 0.505 |
| Antiviral | Yes |
| Prediction | 0.550202 |